This systematic review aimed to evaluate the evidence on urinary and serum biomarkers, specifically CD163, CD206, CD25, and MCP‐1, and combinations thereof for detecting disease activity in AAV. This evidence concerns the gene IL2RA and anti-neutrophil cytoplasmic antibody-associated vasculitis.